Bli medlem
Bli medlem

Du är här


CellaVision AB: Presents the third quarter 2016 on October 27 at 11:00 CET

CellaVision presents the third quarter 2016 on October 27 at 11:00 CET

The information was submitted to the public on October 17, 2016 at 8:20 CET

CellaVision will publish the interim report for the third quarter on October
27, 2016 at 08:20 CET. The report will be available at

In connection with the release of the interim report analysts, investors and
media are hereby invited to a telephone conference and audio webcast at 11:00
CET where Zlatko Rihter, CEO, will present and comment the report.

The presentation will be in English via a conference call or audio webcast:

Phone number for the conference:

SE: +46 856642508

UK: +44 2030089808

US: +1 8558315946

No pre-registration is required. Please dial in 5-10 minutes prior to the
scheduled start time in order to facilitate a timely start.

About CellaVision

CellaVision is an innovative, global medical technology company that develops
and sells its own leading systems for routine analysis of blood and other
body fluids in health care services. The products rationalize manual
laboratory work, and secure and support effective workflows and skills
development within and between hospitals. The company has leading-edge
expertise in image analysis, artificial intelligence and automated
microscopy. Sales are via global partners with support from the mother
company in Lund and by the market support organizations in the US, Canada,
China, Japan, Dubai, Korea, Australia and France. In 2015 sales were SEK 239
million and sales continue to increase, with a growth target of at least 15 %
per year over an economic cycle. CellaVision's registered office is in Lund,
Sweden. The share is listed on the Nasdaq Stockholm, Small Cap list. Read
more at



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: CellaVision AB via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.